Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516603 | SCV000615173 | uncertain significance | not specified | 2016-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001851461 | SCV002175158 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233677 | SCV003931475 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233678 | SCV003931476 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537860 | SCV004115526 | uncertain significance | SETX-related disorder | 2023-01-30 | criteria provided, single submitter | clinical testing | The SETX c.3028C>T variant is predicted to result in the amino acid substitution p.Arg1010Cys. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |